Itolizumab 调节效应细胞上的激活性和抑制性信号,增强其对 CD318+肿瘤细胞系的细胞毒性
Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文,按发表时间由近到远排列。期刊指标供参考,不代表单项研究的证据强度。
Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines.
The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancer.
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。